The Centre aims to expand the reach of affordable medicines by opening 25,000 Jan Aushadhi Kendras across India by March 31, 2027. Currently, 15,000 such outlets provide cost-effective medicines and medical devices.
Growth of the Affordable Medicines Initiative
As reported by The Hindu Business Line, the Department of Pharmaceuticals launched this initiative in 2008. It operates under the Ministry of Chemicals & Fertilizers. The goal is to make generic drugs accessible at lower prices.
Over time, the scheme has grown to offer 2,047 drugs and 300 types of surgical equipment, which cost 50% to 80% less than branded alternatives. Notably, the government achieved its target of 15,000 Kendras by January 31, 2025, ahead of the March 2025 deadline.
Wide Range of Medicines and Medical Devices
The Jan Aushadhi Kendras provide medicines across 29 therapeutic categories, including:
- Antibiotics and anti-infectives
- Anti-cancer drugs
- Anti-diabetics
- Cardiovascular medicines
- Analgesics and antipyretics
- Gastrointestinal agents
- Vitamins, minerals, and food supplements
Additionally, they offer surgical equipment and essential medical consumables such as masks, orthopedic rehabilitation products, surgical dressings, syringes, needles, sanitary napkins, sutures, diapers, rubber gloves, oximeters, and rapid antigen test kits.
Massive Cost Savings for Citizens
In FY 2023-24, Jan Aushadhi Kendras recorded ₹1,470 crore in sales, resulting in ₹7,350 crore in savings for the public. By February 28, 2025, sales for FY 2024-25 had already reached ₹1,760 crore. Over the last decade, the number of Kendras has grown 180 times, while sales have surged 200 times, generating total savings of ₹30,000 crore for citizens.
Week-Long Celebration Ahead of Jan Aushadhi Diwas
Union Minister JP Nadda, who oversees Chemicals & Fertilizers and Health & Family Welfare, flagged off a week-long celebration ahead of Jan Aushadhi Diwas to highlight the initiative’s success and impact.